2002 Results
Sort By:
Published on March 21, 2017
Like many hospitals affiliated with medical schools and medical research, doctors at Vidant Health in Eastern North Carolina had been dabbling in the use of liquid biopsies, to both ease the burden of invasive tissue biopsy procedures, and to learn about how well it could provide relevant information to guide…
Published on March 21, 2017
In 1928, H.B. Reese, a former dairy farmer working as a shipping foreman for Milton S. Hershey, became inspired and decided to strike out on his own, opening The Harry Burnett Reese Candy Company in the basement of his house. Mr. Reese created one the most popular and beloved confectionery treats—Reese’s…
Published on March 16, 2017
Tempus said today it is partnering with breast cancer specialist and research teams at the University of Chicago Medicine and Biological Sciences (UCM) to detect novel patterns that can predict how patients will respond to treatment. The collaboration, whose value was not disclosed, is designed to improve and personalize treatment…
Published on February 21, 2017
Georgia State University (GSU) researchers have just published new results showing that high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer. Researchers are concerned that the dire outcome of this group could indicate that high-risk, African-American breast cancer patients are not…
Published on February 21, 2017
Interpace Diagnostics said today it has launched a research collaboration with Viatar CTC Solutions focused on detecting and characterizing early cancer in liquid biopsies. The collaboration—whose value was not disclosed—will apply Viatar's novel circulating tumor cell collection technology in combination with Interpace’s marketed PancraGEN™ assay, designed to help assess indeterminate…
Published on February 7, 2017
“Geology is the study of pressure and time. That’s all it takes really… pressure… and time…,” bellows Morgan Freeman’s character, Red, when foreshadowing his friend Andy Dufresne’s harrowing escape from prison in the critically acclaimed movie Shawshank Redemption. Oddly enough, this same logic can be applied to antibiotic resistance, although…
Published on February 6, 2017
Strata Oncology said today it will support Epizyme's ongoing Phase II clinical trial of tazemetostat in patients with relapsed or refractory non-Hodgkins lymphoma (NHL). Under the agreement the company will offer patient identification and enrollment for Epizyme’s trial through a clinical collaboration whose value was not disclosed. The collaboration is…
Published on February 3, 2017
A pilot project designed to advance precision medicine for people with cancer in Canada was launched today by a research institution and two of the country’s leading cancer centers. The Terry Fox Research Institute (TFRI), the Princess Margaret Cancer Centre in Toronto, and the BC Cancer Agency in Vancouver, will…
Published on February 3, 2017
The National Cancer Institute (NCI) recently completed a material transfer agreement with German autoantibody screening and diagnostic developer Protagen AG, for the use of Protagen’s SeroTag immune system profile technology. The collaboration will be led by Jeffrey Schlom, Ph.D., chief of the laboratory of tumor Immunology and biology at the…
Published on February 3, 2017
Philadelphia Coalition for a Cure (PC4C) said today it will partner with Children's Hospital of Orange County (CHOC) on a study of brain tumors in adults and children that will use NantHealth’s GPS Cancer molecular profiling and diagnostics test. GPS Cancer integrates whole genome (DNA) sequencing of over 20,000 genes…
Published on February 1, 2017
GenomeDx said today that its Decipher Classifier tests and Decipher Genomics Resource Information Database (GRID) will be used by Astellas to identify active-surveillance prostate cancer patients who may benefit from Xtandi (enzalutamide), the drug it co-markets with Medivation. The value of the collaboration was not disclosed. Astellas has agreed to…
Published on January 24, 2017
Scientists at The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that should aid in the subclassification of the disease, and may help target therapies that are most appropriate for each patient. The new study, published recently in Nature through an article…
Published on January 17, 2017
An international collaboration led by researchers at the Wellcome Trust Sanger Institute has shown that truly personalized therapy will be possible in the future for people with cancer. Details of how a knowledge bank could be used to find the best treatment option for people with acute myeloid leukemia (AML)…
Published on January 16, 2017
A new study from investigators at 10x Genomics and the Fred Hutchinson Cancer Research Center demonstrated the ability of a newly developed single-cell RNA-sequencing (scRNA-seq) system that can be used to dissect transcriptomic heterogeneity from patients with acute myeloid leukemia (AML). Findings from the new study were published online today…
Published on January 11, 2017
A new study by an international team of scientists lead by researchers at Columbia University Medical Center (CUMC), and New York-Presbyterian has just found that several genes previously implicated only in rare, severe forms of pediatric epilepsy also contribute to common forms of the disorder. The findings from the study…